NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-Reactivity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-Reactivity

Published:2021-09-16 Issue:6 Volume:2 Page:648-665
ISSN:2643-3230
Container-title:Blood Cancer Discovery
language:en
Short-container-title:Blood Cancer Discov

Author:

Richards Rebecca M.,Zhao Feifei,Freitas Katherine A.,Parker Kevin R.^ORCID,Xu Peng,Fan Amy^ORCID,Sotillo Elena,Daugaard Mads^ORCID,Oo Htoo Zarni,Liu Jie,Hong Wan-Jen^ORCID,Sorensen Poul H.,Chang Howard Y.,Satpathy Ansuman T.^ORCID,Majzner Robbie G.^ORCID,Majeti Ravindra,Mackall Crystal L.^ORCID

Funder

Stanford Maternal Child Health Research Institute

St. Baldrick's Foundation Fellowship

NIH

SU2C–St. Baldrick's Foundation Pediatric Cancer Dream Team Translational Research Grant

Entertainment Industry Foundation

American Association for Cancer Research

Scientific Partner of SU2C

Parker Institute for Cancer Immunotherapy

Leukemia and Lymphoma Society Translational Research Program Grant

Cancer Research Institute

Burroughs Wellcome Fund

Publisher

American Association for Cancer Research (AACR)

Subject

General Medicine

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric antigen receptor T-cell therapy in acute myeloid leukaemia: Novel therapeutic approaches to longstanding challenges;Gene Reports;2024-09

2. T cell-redirecting therapies in hematological malignancies: Current developments and novel strategies for improved targeting;Molecular Therapy;2024-09

3. Rational combinatorial targeting by adapter CAR-T-cells (AdCAR-T) prevents antigen escape in acute myeloid leukemia;Leukemia;2024-08-03

4. Synthetic biology approaches for enhancing safety and specificity of CAR-T cell therapies for solid cancers;Cytotherapy;2024-08

5. Identification of two key biomarkers CD93 and FGL2 associated with survival of acute myeloid leukaemia by weighted gene co‐expression network analysis;Journal of Cellular and Molecular Medicine;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3